The pace of psychedelic research continued its acceleration during 2021, culminating in several fascinating and groundbreaking studies. As the year comes to a close, Psychedelic Science Review is acknowledging some...
Even at therapeutic doses, ibogaine may cause potentially life-threatening cardiac arrhythmia. Science is beginning to unravel the pharmacological factors that may underlie ibogaine-induced cardiotoxicity.
Scientists know there’s more to magic mushrooms than just psilocybin. But as the psychedelic industry begins taking shape, could the mushroom itself be left behind?
Mescaline is the best-known phenethylamine in psychedelic cacti; but what about the other “minor” compounds in those cacti?
Data released by Filament Health shows why it’s important to understand the basic chemical makeup of magic mushrooms.
The path toward therapeutic psychedelic-based drugs is becoming clearer as scientists understand more about how they are processed in the body.
People tread lightly with this psychoactive species because it contains toxic compounds. But what benefits may be hidden inside?
These aren’t the truffles you’ll find in a restaurant, and they’re also quite distinct from psychedelic mushrooms.
The names may sound familiar, but these compounds reveal more about nature’s complex chemical cocktail in toad venom.
Ketamine and psilocybin both exert rapid antidepressant effects. Could these effects be explained by a common mechanism that promotes neurogenesis?
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.
